217 followers
An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma https://t.co/babGgzFTd7
An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma https://t.co/babGgzFTd7
An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma https://t.co/rwsnXHDIwU https://t.co/jj8PLC9L0U
New research: An enhanced genetic mutation-based model for predicting the efficacy of immune checkpoint inhibitors in patients with melanoma: Background Programmed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as… https://t.co